OptimizeRx Corp (OPRX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net revenue | 29,195 | 21,928 | 21,309 | 18,812 |
| Cost of revenues, exclusive of depreciation and amortization presented separately below | 10,560 | 8,584 | 7,862 | 7,108 |
| Gross profit | 18,635 | 13,344 | 13,447 | 11,704 |
| Goodwill, impairment loss | - | - | 7,489 | - |
| General and administrative expenses | 14,372 | 14,364 | 13,425 | 14,380 |
| Depreciation and amortization | 1,074 | 1,094 | 1,095 | 1,073 |
| Total operating expenses | 15,446 | 15,458 | 22,009 | 15,453 |
| Income (loss) from operations | 3,189 | -2,114 | -8,562 | -3,749 |
| Other income | - | - | - | 75 |
| Interest income, other | - | - | - | 106 |
| Other income | 37 | 39 | 38 | - |
| Interest income | 90 | 88 | 107 | - |
| Interest expense | 1,603 | 1,297 | 1,524 | 1,528 |
| Total other expense, net | -1,476 | -1,170 | -1,379 | -1,347 |
| Income (loss) before provision for income taxes | 1,713 | -3,284 | -9,941 | -5,096 |
| Income tax benefit (expense) | 181 | -1,085 | -817 | -1,088 |
| Net income (loss) | 1,532 | -2,199 | -9,124 | -4,008 |
| Income (loss) per share basic (in dollars per share) | 0.08 | -0.12 | -0.5 | -0.22 |
| Income (loss) per share diluted (in dollars per share) | 0.08 | -0.12 | -0.5 | -0.22 |
| Weighted average number of shares outstanding basic (in shares) | 18,510,834 | 18,470,808 | 18,323,542 | 18,257,879 |
| Weighted average number of shares outstanding diluted (in shares) | 19,015,496 | 18,470,808 | 18,323,542 | 18,257,879 |